Preferred Label : hypotensive agent, nos;

Details


Main resources

You can consult :


https://www.cochrane.org/fr/CD004184/HTN_est-il-preferable-de-prendre-les-antihypertenseurs-le-matin-ou-le-soir-pour-traiter-lhypertension
2024
United Kingdom
review of literature
french abstract
Israel
Take
hypotensive agent, nos
Every Morning
Is Preferred
Antihypertensive Agent
Hypertension
hypertensive disease, nos
Illinois
What Month is it
Every Evening
Interleukin
antihypertensive agents
hypertension
Treat

---
https://www.minerva-ebp.be/FR/Article/2330
2023
Belgium
critical appraisal or critical reading
statine
Disease
aspirin
disease of cardiovascular system, nos
Diseases of the cardiovascular system
combined modality therapy
preventive treatment, nos
hypotensive agent, nos
statine
cardiovascular diseases
Antihypertensive agents
principal
acetylsalicylic acid
antihypertensive agents
primary prevention
Diseases
cardiovascular prevention
association
hydroxymethylglutaryl-coa reductase inhibitors

---
https://www.minerva-ebp.be/FR/Article/2319
2023
Belgium
critical appraisal or critical reading
hypotensive agent, nos
Antihypertensive agents
antihypertensive agents

---
https://www.minerva-ebp.be/FR/Article/2214
2020
Belgium
critical appraisal or critical reading
bedtime
antihypertensive agents
absorbent pads
hypotensive agent, nos
Antihypertensive agents

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/23993
2019
Canada
dissertations, academic
Economic Evaluation
Economics
costs and cost analysis
Economy
adjustment, nos
antihypertensive agents
pharmacists
Antihypertensive agents
hypotensive agent, nos
pharmacist
Cost-Benefit analysis

---
http://www.sudoc.fr/203627458
2017
false
false
false
France
French
dissertations, academic
therapeutics
angiotensin II receptor antagonists
efficiency
achievement
effective
angiotensin receptor antagonists
hypotensive agent, nos
angiotensin-converting enzyme inhibitor agent, nos
operations research
antihypertensive agents
angiotensin-converting enzyme inhibitors
Meta-Analysis
angiotensin ii receptor antagonist, nos
Treatment Efficacy
meta-analysis as topic
clinical
meta-analysis
treatment outcome

---
http://www.sudoc.fr/203630513
2017
false
false
false
France
French
dissertations, academic
pressure
hypopnea
obstructive sleep apnea syndrome
sleep apnea, obstructive
persistent
hypotensive agent, nos
patients
antihypertensive agents
evolving
status post
data collection
positive
pressure, nos
continuous positive airway pressure
treaties
has development
has patient
pressure
international cooperation

---
http://www.sudoc.fr/203634411
2017
false
false
false
France
French
dissertations, academic
achievement
thiazide diuretic, nos
effective
Meta-Analysis
Treatment Efficacy
sodium chloride symporter inhibitors
antihypertensive agents
meta-analysis as topic
efficiency
calcium channel blocking agent, nos
operations research
clinical
calcium channel blockers
hypotensive agent, nos
therapeutics
decision aids
diuretics, thiazide
meta-analysis
treatment outcome
decision support techniques

---
http://www.sudoc.fr/224138081
2017
false
false
false
France
French
dissertations, academic
quantity
geriatrics
hospitalization
medicine
abate
status post
antihypertensive agents
hypotensive agent, nos
Lecture
hospital admission, nos
general practitioners
quantitative
treaties
has development
Geriatricians
decreased
medicine
temefos
Lecture
international cooperation
Geriatricians

---
Nous contacter.
18/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.